Jefferies Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$829K Buy
+10,030
New +$829K 0.01% 523
2022
Q1
Sell
-47,300
Closed -$6.13M 1081
2021
Q4
$6.13M Sell
47,300
-42,500
-47% -$5.51M 0.04% 177
2021
Q3
$10.2M Buy
89,800
+83,578
+1,343% +$9.46M 0.07% 108
2021
Q2
$644K Sell
6,222
-63,301
-91% -$6.56M ﹤0.01% 683
2021
Q1
$5.81M Buy
69,523
+50,915
+274% +$4.26M 0.05% 174
2020
Q4
$1.7M Sell
18,608
-3,992
-18% -$364K 0.01% 413
2020
Q3
$1.8M Buy
22,600
+12,600
+126% +$1.01M 0.02% 334
2020
Q2
$691 Buy
10,000
+6,151
+160% +$425 0.01% 487
2020
Q1
$252K Sell
3,849
-23,229
-86% -$1.52M ﹤0.01% 800
2019
Q4
$2.11M Buy
27,078
+810
+3% +$63K 0.02% 523
2019
Q3
$1.93M Buy
26,268
+9,603
+58% +$704K 0.01% 546
2019
Q2
$1.03M Sell
16,665
-64,335
-79% -$3.96M 0.01% 693
2019
Q1
$5.17M Buy
81,000
+76,374
+1,651% +$4.87M 0.04% 168
2018
Q4
$236K Buy
4,626
+2,121
+85% +$108K ﹤0.01% 1083
2018
Q3
$145K Buy
2,505
+465
+23% +$26.9K ﹤0.01% 1427
2018
Q2
$99K Buy
+2,040
New +$99K ﹤0.01% 1427
2018
Q1
Sell
-233,061
Closed -$8.76M 1605
2017
Q4
$8.76M Buy
233,061
+53,268
+30% +$2M 0.04% 115
2017
Q3
$6.55M Buy
179,793
+136,152
+312% +$4.96M 0.04% 150
2017
Q2
$1.72M Buy
43,641
+17,802
+69% +$702K 0.01% 523
2017
Q1
$810K Buy
25,839
+5,859
+29% +$184K 0.01% 750
2016
Q4
$624K Sell
19,980
-16,014
-44% -$500K ﹤0.01% 785
2016
Q3
$1.45M Sell
35,994
-140,745
-80% -$5.65M 0.01% 449
2016
Q2
$5.88M Buy
176,739
+57,462
+48% +$1.91M 0.03% 105
2016
Q1
$3.51M Buy
119,277
+24,633
+26% +$724K 0.02% 191
2015
Q4
$2.49M Buy
94,644
+85,644
+952% +$2.26M 0.01% 262
2015
Q3
$213K Sell
9,000
-37,086
-80% -$878K ﹤0.01% 1058
2015
Q2
$1.09M Sell
46,086
-210,468
-82% -$5M 0.01% 557
2015
Q1
$6.09M Buy
256,554
+153,384
+149% +$3.64M 0.03% 129
2014
Q4
$2.19M Buy
+103,170
New +$2.19M 0.01% 263
2014
Q2
Sell
-94,860
Closed -$1.17M 1452
2014
Q1
$1.17M Buy
94,860
+60,606
+177% +$749K 0.01% 389
2013
Q4
$375K Sell
34,254
-20,010
-37% -$219K ﹤0.01% 716
2013
Q3
$630K Buy
54,264
+12,696
+31% +$147K 0.01% 560
2013
Q2
$466K Buy
+41,568
New +$466K 0.01% 562